Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression

Introduction The compassionate use of intranasal esketamine is approved in Spain for treatment-resistant depression (TRD). Objectives The objective of the study is to assess the clinical stability in the medium-term follow-up of patients with TRD after esketamine use. Methods Descriptive, retrosp...

Full description

Bibliographic Details
Main Authors: D. Hernandez Huerta, A. De Santiago Diaz, C. Rodriguez Gomez-Carreño, M.A. Abril Garcia, F. Toledo Romero, A. Guerrero Morcillo, C.J. Martinez Pastor, M. Vega Piñero
Format: Article
Language:English
Published: Cambridge University Press 2022-06-01
Series:European Psychiatry
Subjects:
Depression
esketamine
Treatment-resistant depression
Online Access:https://www.cambridge.org/core/product/identifier/S0924933822007623/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S0924933822007623/type/journal_article

Similar Items